arrow
返回
H

Howard A. Burris

university of toronto

117H指数
1.1K论文数
7.2W被引数
收录论文 223
发表时间
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanomaLOGIC 2研究的通俗语言摘要:恩考拉非尼、比尼美替尼以及第三种药物用于BRAF V600突变型黑色素瘤患者
err2026-04-01
err0
errOAAI
errDummer, Reinhard; Sandhu, Shahneen; Miller Jr, Wilson H.; Butler, Marcus O.; Taylor, Matthew H.; Heinzerling, Lucie; Blank, Christian U.; Couselo, Eva Munoz; Burris, Howard A.; Postow, Michael A.; Chmielowski, Bartosz; Middleton, Mark R.; Berking, Carola; Hassel, Jessica C.; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F.; Polli, Anna; Harney, Allison S.; Di Pietro, Alessandra; Ascierto, Paolo A.
err分享
err收藏
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 studyZanidatamab 联合化疗作为HER2阳性晚期胃食管腺癌患者的一线治疗方案:一项多中心、单臂、II期研究的主要结果
err2025-06-02
err0
PREAI
errElena Elimova; Jaffer Ajani; Howard Burris; Crystal S Denlinger; Syma Iqbal; Yoon-Koo Kang; Jwa Hoon Kim; Keun-Wook Lee; Bruce Lin; Rutika Mehta; Do-Youn Oh; Sun Young Rha; Young Mi Seol; Lin Yang; Mark A Ozog; Phillip M Garfin; Geoffrey Ku
err分享
err收藏
Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab循环肿瘤DNA监测和接受阿特珠单抗治疗的转移性实体瘤患者的血液肿瘤突变负荷
err2025-05-28
err0
errOAAI
errCharles Swanton; Russell W. Madison; Candice Francheska B. Tambaoan; Funda Meric-Bernstam; Christopher J. Sweeney; Razelle Kurzrock; Howard A. Burris III; David R. Spigel; Hanna Tukachinsky; Jason Hughes; Julia Malato; Bongin Yoo; Tania Szado; Cheryl Schwab; Lincoln W. Pasquina; Amaya Gasco; Katja Schulze; Claire F. Friedman
err分享
err收藏
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study度伐鲁单抗联合化疗在晚期胆道癌中的应用:III期TOPAZ-1研究的3年总生存期更新
err2025-05-15
err0
errOAAI
errDo-Youn Oh; Aiwu Ruth He; Shukui Qin; Li-Tzong Chen; Takuji Okusaka; Jin Won Kim; Thatthan Suksombooncharoen; Myung Ah Lee; Masayuki Kitano; Howard A. Burris; Mohamed Bouattour; Suebpong Tanasanvimon; Renata Zaucha; Antonio Avallone; Juan Cundom; Aleksandra Kuzko; Julie Wang; Ioannis Xynos; Arndt Vogel; Juan W. Valle
err分享
err收藏
Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in advanced biliary tract cancer (aBTC)三年生存率、安全性及扩展长期生存者(eLTS)分析:来自度伐利尤单抗(D)联合化疗在晚期胆道癌(aBTC)中的III期TOPAZ-1研究
err2024-12-01
err1
PREAI
errOh, D-Y.; He, A. R.; Qin, S.; Chen, L-T.; Okusaka, T.; Vogel, A.; Kim, J. W.; Suksombooncharoen, T.; Lee, M. A.; Kitano, M.; Burris, H. A.; Bouattour, M.; Tanasanvimon, S.; Zaucha, R. E.; Avallone, A.; Cundom, J. E.; Kuzko, A.; Wang, J.; Xynos, I.; Valle, J. W.
err分享
err收藏
err分享
err收藏
Subsequent anticancer therapy (SAT) analysis from 3-year follow-up of the phase III TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in biliary tract cancer (BTC)后续抗肿瘤治疗(SAT)分析来自durvalumab联合吉西他滨和顺铂治疗胆道癌(BTC)的III期TOPAZ-1研究3年随访数据
err2024-09-01
err1
PREAI
errVogel, A.; Oh, D-Y.; He, A. R.; Qin, S.; Chen, L-T.; Okusaka, T.; Kim, J. W.; Suksombooncharoen, T.; Lee, M. A.; Kitano, M.; Burris, H. A.; Bouattour, M.; Tanasanvimon, S.; Zaucha, R. E.; Avallone, A.; Cundom, J. E.; Kuzko, A.; Wang, J.; Xynos, I.; Valle, J. W.
err分享
err收藏
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study在1期KEYNOTE-603研究中,单独或与Pembrolizumab联合使用个体化新抗原治疗mRNA-4157 (V940) 的T细胞反应
err2024-08-08
err1
PREAI
errGainor, Justin F.; Patel, Manish R.; Weber, Jeffrey S.; Gutierrez, Martin; Bauman, Julie E.; Clarke, Jeffrey M.; Julian, Ricklie; Scott, Aaron J.; Geiger, Jessica L.; Kirtane, Kedar; Robert-Tissot, Celine; Coder, Brandon; Tasneem, Moomal; Sun, Jing; Zheng, Wei; Gerbereux, Lauren; Laino, Andressa; Porichis, Filippos; Pollard, Jack Russella; Hou, Peijie; Sehgal, Vasudha; Chen, Xing; Morrissey, Manju; Daghestani, Hikmat N.; Feldman, Igor; Srinivasan, Lakshmi; Frederick, Joshua P.; Brown, Michelle; Aanur, Praveen; Meehan, Robert; Burris III, Howard A.
err分享
err收藏
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
err2024-08-01
err15
PREAI
errOh, Do-Youn; He, Aiwu Ruth; Bouattour, Mohamed; Okusaka, Takuji; Qin, Shukui; Chen, Li-Tzong; Kitano, Masayuki; Lee, Choong-kun; Kim, Jin Won; Chen, Ming -Huang; Suksombooncharoen, Thatthan; Ikeda, Masafumi; Lee, Myung Ah; Chen, Jen-Shi; Potemski, Piotr; Burris, Howard A.; Ostwal, Vikas; Tanasanvimon, Suebpong; Morizane, Chigusa; Zaucha, Renata E.; Mcnamara, Mairead G.; Avallone, Antonio; Cundom, Juan E.; Breder, Valeriy; Tan, Benjamin; Shimizu, Satoshi; Tougeron, David; Evesque, Ludovic; Petrova, Mila; Zhen, David B.; Gillmore, Roopinder; Gupta, Vineet Govinda; Dayyani, Farshid; Park, Joon Oh; Buchschacher Jr, Gary L.; Rey, Felipe; Kim, Hyosung; Wang, Julie; Morgan, Claire; Rokutanda, Nana; Zotkiewicz, Magdalena; Vogel, Arndt; Valle, Juan W.
err分享
err收藏
Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in biliary tract cancer (BTC)
err2024-06-01
err0
PREAI
errOh, D-Y.; He, A. R.; Qin, S.; Chen, L-T.; Okusaka, T.; Vogel, A.; Kim, J. W.; Suksombooncharoen, T.; Lee, M. A.; Kitano, M.; Burris, H. A.; Bouattour, M.; Tanasanvimon, S.; Zaucha, R. E.; Avallone, A.; Cundom, J. E.; Kuzko, A.; Wang, J.; Xynos, I.; Valle, J. W.
err分享
err收藏
The evolving landscape of tissue-agnostic therapies in precision oncology精确肿瘤学中组织不可知疗法的发展前景
err2024-05-30
err4
errOAAI
errSubbiah, Vivek; Gouda, Mohamed A.; Ryll, Bettina; Burris, Howard A.; Kurzrock, Razelle
err分享
err收藏
Tumor informed circulating tumor DNA monitoring for early treatment response and survival outcomes on trastuzumab plus pertuzumab
err2024-03-22
err0
PREAI
errKurzrock, Razelle; Childress, Merrida; Li, Wenshu; Muse, Anna; Malato, Julia; Wang, Yong; Liu, Minetta; Aleshin, Alexey; Wang, Richard S.; Thierauf, Julia; Sweeney, Christopher J.; Hainsworth, John; Szado, Tania; Young, Amanda; Schulze, Katja; Spigel, David; Meric-Bernstam, Funda; Swanton, Charles; Burris, Howard A.
err分享
err收藏
A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast canceralpelisib诱发晚期实体瘤和乳腺癌患者高血糖的风险分析
err2024-03-04
err5
errOAAI
errRodon, Jordi; Demanse, David; Rugo, Hope S.; Burris, Howard A.; Simo, Rafael; Farooki, Azeez; Wellons, Melissa F.; Andre, Fabrice; Hu, Huilin; Vuina, Dragica; Quadt, Cornelia; Juric, Dejan
err分享
err收藏
Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors
err2024-02-01
err4
errOAAI
errPerez, B.; Aljumaily, R.; Marron, T. U.; Shafique, M. R.; Burris, H.; Iams, W. T.; Chmura, S. J.; Luke, J. J.; Edenfiield, W.; Sohal, D.; Liao, X.; Boesler, C.; Machl, A.; Seebeck, J.; Becker, A.; Guenther, B.; Rodriguez-Gutierrez, A.; Antonia, S. J.
err分享
err收藏
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours
err2024-01-29
err10
errOAAI
errBurris, Howard A.; Berlin, Jordan; Arkenau, Tobias; Cote, Gregory M.; Lolkema, Martijn P.; Ferrer-Playan, Jordi; Kalapur, Anup; Bolleddula, Jayaprakasam; Locatelli, Giuseppe; Goddemeier, Thomas; Gounaris, Ioannis; de Bono, Johann
err分享
err收藏
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
err2023-11-29
err5
PREAI
errMayer, Erica L.; Tayob, Nabihah; Ren, Siyang; Savoie, Jennifer J.; Spigel, David R.; Burris, Howard A.; Ryan, Paula D.; Harris, Lyndsay N.; Winer, Eric P.; Burstein, Harold J.
err分享
err收藏
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
err2023-09-25
err7
errOAAI
errOh, Do-Youn; He, Aiwu Ruth; Qin, Shukui; Chen, Li-Tzong; Okusaka, Takuji; Vogel, Arndt; Kim, Jin Won; Suksombooncharoen, Thatthan; Lee, Myung Ah; Kitano, Masayuki; Burris, Howard; Bouattour, Mohamed; Tanasanvimon, Suebpong; McNamara, Mairead G.; Zaucha, Renata; Avallone, Antonio; Tan, Benjamin; Cundom, Juan; Lee, Choong-kun; Takahashi, Hidenori; Ikeda, Masafumi; Chen, Jen-Shi; Wang, Julie; Makowsky, Mallory; Rokutanda, Nana; Zotkiewicz, Magdalena; Kurland, John F.; Cohen, Gordon; Valle, Juan W.
err分享
err收藏
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
err2023-06-12
err11
errOAAI
errSchmid, Peter; Cortes, Javier; Joaquim, Ana; Janez, Noelia Martinez; Morales, Serafin; Diaz-Redondo, Tamara; Blau, Sibel; Neven, Patrick; Lemieux, Julie; Garcia-Saenz, Jose Angel; Hart, Lowell; Biyukov, Tsvetan; Baktash, Navid; Massey, Dan; Burris, Howard A., III; Rugo, Hope S.
err分享
err收藏
Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours
err2023-03-04
err15
errOAAI
errJohnson, Melissa L. L.; Wang, Judy S. S.; Falchook, Gerald; Greenlees, Carol; Jones, Suzanne; Strickland, Donald; Fabbri, Giulia; Kennedy, Caroline; Pease, J. Elizabeth; Sainsbury, Liz; MacDonald, Alexander; Schalkwijk, Stein; Szekeres, Philip; Cosaert, Jan; Burris, Howard
err分享
err收藏